GLAXF - GlaxoSmithKline PLC (GSK) CEO Emma Walmsley on Q4 2021 Results - Earnings Call Transcript
GlaxoSmithKline PLC (GSK) Q4 2021 Earnings Conference Call February 09, 2022, 09:00 ET Company Participants Nick Stone - Head, Global Investor Relations Emma Walmsley - CEO & Director Luke Miels - Chief Commercial Officer Deborah Waterhouse - CEO, ViiV Healthcare Brian McNamara - CEO, GSK Consumer Healthcare Iain Mackay - CFO & Executive Director Hal Barron - Chief Scientific Officer, President of R&D and Director Roger Connor - President, Vaccines & Global Health Conference Call Participants James Gordon - JPMorgan Chase & Co. Keyur Parekh - Goldman Sachs Group Graham Parry - Bank of America Merrill Lynch Simon Baker - Redburn Timothy Anderson - Wolfe Research Emmanuel Papadakis - Deutsche Bank Jo Walton - Crédit Suisse Stephen Scala - Cowen and Company Andrew Baum - Citigroup Laura Sutcliffe - UBS Seamus Fernandez - Guggenheim Securities Kerry Holford - Berenberg Mark Purcell - Morgan Stanley Peter Welford - Jefferies Presentation Operator
For further details see:
GlaxoSmithKline PLC (GSK) CEO Emma Walmsley on Q4 2021 Results - Earnings Call Transcript